Patel Samir Rashmikant (CIK 1702447) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-17). Recent activity: Buy AKTX (1,209 shares), Buy AKTX (15,466 shares), Buy AKTX (5,799 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-17 | Akari Therapeutics Plc (AKTX) | Director | Buy | 1,209 | $9,672 |
| 2026-07-17 | Akari Therapeutics Plc (AKTX) | Director | Buy | 15,466 | $6 |
| 2026-07-17 | Akari Therapeutics Plc (AKTX) | Director | Buy | 5,799 | $2 |
来源：SEC Form 4 申报文件 · 截至 2026-07-17